Skip to main content

Table 3 Summary of the meta-analysis results for the associations between the selected variants and CRC risk

From: Associations between variants on ADIPOQ and ADIPOR1 with colorectal cancer risk: a chinese case-control study and updated meta-analysis

SNP Subjects (case/control) Genotype Fixed-effects model (OR, 95% CI), p-value Random-effects model (OR, 95% CI), p-value Q-value/df P value for Q test I 2 P value of Egger’s test
rs1342387 1871/2597 CC 1 1     
CT 0.80 (0.70-0.92), 0.002 0.82 (0.67-1.00), 0.052 8.55/4 0.0733 53.2% 0.307
TT 0.71 (0.59- 0.86), < 0.001 0.71 (0.59- 0.86), < 0.001 3.28/4 0.5114 0% 0.351
CT + TT 0.77 (0.68- 0.89), < 0.001 0.79 (0.66- 0.95), 0.011 8.06/4 0.089 50.4% 0.209
rs266729 3635/4411 CC 1 1     
CG 0.97 (0.79-1.19), 0.756 0.97 (0.77-1.22), 0.784 6.42/5 0.267 22.2% 0.253
GG 0.94 (0.84-1.05), 0.262 0.93 (0.78-1.10), 0.381 11.95/5 0.036 58.2% 0.288
CG + GG 0.95 (0.86-1.03), 0.221 0.93 (0.81-1.08), 0.354 14.45/6 0.025 58.5% 0.401
rs2241766 1519/2310 TT 1 1     
TG 1.23 (1.08-1.40), 0.002 1.16 (0.92-1.46), 0.202 15.83/6 0.147 62.1% 0.120
GG 1.19 (0.92-1.53), 0.174 1.19 (0.91-1.56), 0.209 6.38/6 0.382 6.0% 0.670
TG + GG 1.22 (1.07-1.37), 0.002 1.18 (0.96-1.43), 0.108 12.93/6 0.044 53.6% 0.173
rs1501299 2749/4005 GG 1 1     
TG 0.92 (0.82-1.02), 0.088 0.95 (0.82-1.05), 0.133 11.34/9 0.253 20.6% 0.083
TT 0.97 (0.81-1.18), 0.946 0.97 (0.81-1.18), 0.782 7.11/8 0.524 0% 0.530
TG + TT 0.92 (0.84-1.02), 0.131 0.93 (0.83-1.04), 0.205 10.49/9 0.312 14.2% 0.086
rs822395 1901/2639 AA 1 1     
AC 1.01 (0.88-1.16), 0.898 1.00 (0.86-1.18), 0.963 5.38/4 0.250 25.7% 0.498
CC 0.92 (0.72-1.17), 0.497 0.92 (0.72-1.17), 0.502 3.04/4 0.551 0% 0.032
AC + CC 0.99 (0.87-1.13), 0.927 0.99 (0.87-1.13), 0.930 3.83/4 0.429 0% 0.793
rs12733285 1401/2139 CC 1 1     
CT 0.86 (0.72-1.03), 0.092 0.86 (0.65-1.13), 0.277 6.81/3 0.0782 56.0% 0.841
TT 0.96 (0.69-1.33), 0.786 0.96 (0.69-1.33), 0.795 1.45/2 0.485 0% 0.958
CT + TT 0.87 (0.74-1.04), 0.108 0.87 (0.66-1.14), 0.304 7.12/3 0.068 57.8% 0.813